Day One Notes for the 40th Annual J.P. Morgan Healthcare Conference, 2022
Sheppard Health Law
JANUARY 11, 2022
While Sinovac primarily addresses the Chinese market, Sinovac has expanded globally and produces the most widely utilized COVID vaccine, accounting for approximately 40% of all COVID vaccine doses administered worldwide. Interestingly, Carbon did not talk about any value-based care approaches in its presentation.
Let's personalize your content